Intra-articular injections for the treatment of osteoarthritis: Focus on the clinical use of hyaluronic acid

Drugs in R and D

Volumn 11, Issue 1, 2011, Pages 13-27

  Iannitti, Tommaso ^a   Lodi, Daniele ^b   Palmieri, Beniamino ^b  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Hyaluronic acid; Osteoarthritis; Rheumatoid arthritis; therapeutic use; treatment

Indexed keywords

BETAMETHASONE; BOTULINUM TOXIN A; BUPIVACAINE; CLODRONIC ACID; COLLAGEN; CORTICOSTEROID; HYALURONIC ACID; INFLIXIMAB; LIDOCAINE; METHYLPREDNISOLONE; MORPHINE; ORTHOKIN; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TENOXICAM; TRIAMCINOLONE HEXACETONIDE; UNCLASSIFIED DRUG;

ANALGESIA; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; LOW DRUG DOSE; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TOTAL KNEE REPLACEMENT; TREATMENT INDICATION; VISUAL ANALOG SCALE;

EID: 79953135003     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.2165/11539760-000000000-00000     Document Type: Review

References (107)

1. Attur MG, Dave M, Akamatsu M, et al. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002 Jan; 10(1):1-4 (Pubitemid 34110787)
2. Fox BA, Stephens MM. Glucosamine/chondroitin/primorine combination therapy for osteoarthritis. Drugs Today (Barc) 2009 Jan; 45(1):21-31
3. Felson DT, Couropmitree NN, Chaisson CE, et al. Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthr Rheum 1998;41:1064-71 (Pubitemid 28265409)
4. Andrianakos AA, Kontelis LK, Karamitsos DG, et al. Prevalence of symptomatic knee, hand and hip osteoarthritis in Greece: the ESORDIG study. J Rheumatology 2006;33:2507-13
5. Michael JW, Schlüter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int 2010 Mar; 107(9):152-62
6. Cymet TC, Sinkov V. Does long-distance running cause osteoarthritis? J Am Osteopath Assoc 2006 Jun; 106(6):342-5 (Pubitemid 43945594)
7. Okada A, Okada Y. Progress of research in osteoarthritis: metalloproteinases in osteoarthritis. Clin Calcium 2009 Nov; 19(11):1593-601
8. McGonagle D, Tan AL, Carey J, et al. The anatomical basis for a novel classification of osteoarthritis and allied disorders. J Anat 2010 Mar; 216(3):279-91
9. Okazaki K, Iwamoto Y. Progress of research in osteoarthritis: gene expression and its regulatory mechanisms in the degenerative cartilage in osteoarthritis. Clin Calcium 2009 Nov; 19(11):1578-85
10. Sofat N. Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol 2009 Oct; 90(5):463-79
11. Chen Q. Mouse models and new therapeutic targets for OA. J Musculoskelet Neuronal Interact 2008 Oct-Dec; 8(4):311-2
12. Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther 2009;11(3):227
13. Huang K, Wu LD. YKL-40: a potential biomarker for osteoarthritis. J Int Med Res 2009 Jan-Feb; 37(1):18-24
14. Fukuda K. Progress of research in osteoarthritis: involvement of reactive oxygen species in the pathogenesis of osteoarthritis. Clin Calcium 2009 Nov; 19(11):1602-6
15. Chevalier X. Intraarticular treatments for osteoarthritis: newperspectives. Curr Drug Targets 2010 May; 11(5):546-60
16. Meyer K, Palmer J. The polysaccharide of the vitreous humor. J Biol Chem 1934;107:629-34
17. Goa KL, Benfield P. Hyaluronic acid: a review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994 Mar; 47(3):536-66
18. Kogan G, Soltés L, Stern R, et al. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 2007 Jan; 29(1):17-25 (Pubitemid 44950153)
19. Laurent TC. The chemistry, biology and medical applications of hyaluronan and its derivatives. London: Portland Press, 1998
20. Arnold W, Fullerton DS, Holder S, et al. Viscosupplementation: managed care issue for osteoarthritis of the knee. J Manag Care Pharm 2007;13(4):S3-19
21. Toole BP. Hyaluronan in morphogenesis. Semin Cell Dev Biol 2001 Apr; 12(2):79-87
22. Olczyk P, Komosińska-Vassev K, Winsz-Szczotka K, et al. Hyaluronan: structure, metabolism, functions, and role in wound healing. Postepy Hig Med Dosw (Online) 2008 Dec. 2; 62:651-9
23. Prehm P. Hyaluronan. In: Vandamme EJ, DeBaets S, Steinbüchel A, editors. Biopolymers: biology, chemistry, biotechnology, applications. Polysaccharides I: polysaccharides from prokaryotes. Vol. 5. Weinheim: Wiley-VCH, 2000:379-404
24. Salter DM, Godolphin JL, Gourlay MS, et al. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol 1996;179:396-402 (Pubitemid 26276109)
25. Knudson CB, Knudson W. Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin Orthop Relat Res 2004: S152-62 (Pubitemid 39362816)
26. Nakamura H, Kenmotsu S, Sakai H, et al. Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res 1995;280:225-33
27. Fujii Y, Fujii K, Nakano K, et al. Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1. FEBS Lett 2003;539:45-50 (Pubitemid 36351285)
28. Yamazaki M, Nakajima F, Ogasawara A, et al. Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J Bone Joint Surg Br 1999;81:508-15 (Pubitemid 29245911)
29. Garcia-Fuentes M, Meinel AJ, Hilbe M, et al. Merkle HP Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials 2009 Oct; 30(28):5068-76
30. Toole BP. Hyaluronan in morphogenesis. J Intern Med 1997;242:35-40 (Pubitemid 27323863)
31. Pavasant P, Shizari T, Underhill CB. Hyaluronan contributes to the enlargement of hypertrophic lacunae in the growth plate. J Cell Sci 1996;109(Pt 2):327-34 (Pubitemid 26057115)
32. Fedarko NS, Termine JD, Young MF, et al. Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cells in vitro. J Biol Chem 1990;265:12200-9
33. Fedarko NS, Vetter UK, Weinstein S, et al. Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J Cell Physiol 1992;151:215-27
34. Kogan G, Soltés L, Stern R, et al. Hyaluronic acid: its function and degradation in in vivo systems. In: Attaur-Rahman, editor. Studies in natural products chemistry: bioactive natural products (part N). Vol. 34. Amsterdam: Elsevier, 2008:789-882
35. Yasuda T. Progress of research in osteoarthritis: pharmacological effects of hyaluronan. Clin Calcium 2009 Nov; 19(11):1644-52
36. Grigolo B, Roseti L, Fiorini M, et al. Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits. Biomaterials 2001;22:2417-24 (Pubitemid 32666233)
37. Park SH, Park SR, Chung SI, et al. Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Artif Organs 2005;29:838-45 (Pubitemid 43934125)
38. Nehrer S, Domayer S, Dorotka R, et al. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 2006;57:3-8 (Pubitemid 43075403)
39. Lepidi S, Grego F, Vindigni V, et al. Hyaluronan biodegradable scaffold for small-caliber artery grafting: preliminary results in an animal model. Eur J Vasc Endovasc Surg 2006;32:411-7 (Pubitemid 44362167)
40. Goldring MB, Goldring SB. Osteoarthritis. J Cell Physiol 2007;213:626-34 (Pubitemid 350058254)
41. Bondeson J, Blom AB, Wainwright S, et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010 Mar; 62(3):647-57
42. Goekoop RJ, Kloppenburg M, Kroon HM, et al. Low innate production of interleukin-1beta and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthritis Cartilage 2010;18(7):942-7
43. Hiramitsu T, Yasuda T, Ito H, et al. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via downregulation of NF-kappa B and p 38. Rheumatology (Oxford) 2006 Jul; 45(7):824-32 (Pubitemid 43985370)
44. Shimizu M, Yasuda T, Nakagawa T, et al. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol 2003 Jun; 30(6):1164-72 (Pubitemid 36666336)
45. Waddell DD, Kolomytkin OV, Dunn S, et al. Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue. Clin Orthop Relat Res 2007 Dec; 465:241-8 (Pubitemid 350306523)
46. Volpi N, Schiller J, Stern R, et al. Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem 2009;16(14):1718-45
47. Soltés L, Mendichi R. Molecular characterization of two host-guest associating hyaluronan derivatives. Biomed Chromatogr 2003;17:376-84 (Pubitemid 37160952)
48. Marshall KW. Intra-articular hyaluronan therapy. Curr Opin Rheumatol 2000;12:468-74
49. Notoya K, Jovanovic DV, Reboul P, et al. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 2000;165:3402-10
50. Yamashita I, Gomis A, Pawlak M, et al. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum 2004;50:314-26 (Pubitemid 38084317)
51. Kreger ST, Voytik-Harbin SL. Hyaluronan concentration within a 3D collagen matrix modulates matrix viscoelasticity, but not fibroblast response. Matrix Biol 2009 July; 28(6):336-46
52. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 2002;32:10-37 (Pubitemid 35001162)
53. Pelletier JP, Martel-Pelletier J. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol Suppl 1993 Aug; 39:19-24 (Pubitemid 23284289)
54. Schiavinato A, Lini E, Guidolin D, et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II: Morphological findings. Clin Orthop Relat Res 1989 Apr; (241):286-99 (Pubitemid 19101273)
55. Grishko V, Xu M, Ho R, et al. Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem 2009 April 3; 284(14):9132-9
56. Takahashi K, Hashimoto S, Kubo T, et al. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000 Jul; 27(7):1713-20 (Pubitemid 30462817)
57. Peng H, Zhou JL, Liu SQ, et al. Hyaluronic acid inhibits nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes in vitro. Inflamm Res 2010;59:519-30
58. Lee YT, Shao HJ, Wang JH, et al. Hyaluronic acid modulates gene expression of connective tissue growth factor (CTGF), transforming growth factor-beta1 (TGF-beta1), and vascular endothelial growth factor (VEGF) in human fibroblast-like synovial cells from advanced-stage osteoarthritis in vitro. J Orthop Res 2010 Apr; 28(4):492-6
59. Zhou JL, Liu SQ, Qiu B, et al. Effects of hyaluronan on vascular endothelial growth factor and receptor-2 expression in a rabbit osteoarthritis model. J Orthop Sci 2009 May; 14(3):313-9
60. Davidson ENB, Vitters EL, Mooren FM, et al. Connective tissue growth factor/ccn2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum 2006;54:1653-61
61. Murata M, Yudoh K, Masuko K. The potential role of vascular endothelial growth factor (vegf) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cartilage 2008;16:279-86 (Pubitemid 351309189)
62. Tanaka E, Aoyama J, Miyauchi M, et al. Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis. Histochem Cell Biol 2005;123:275-81 (Pubitemid 40674678)
63. Enomoto H, Inoki I, Komiya K, et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 2003;162:171-81 (Pubitemid 36041999)
64. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993;39:3-9 (Pubitemid 23284286)
65. Kelly MA, Moskowitz RW, Lieberman JR. Hyaluronan therapy: looking toward the future. Am J Orthop 2004;33(2 Suppl.): 23-8
66. Vitanzo PC, Sennett BJ. Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop 2006;35:421-8
67. Wen DY. Intra-articular hyaluronic acid injections for knee osteoarthritis. Am Fam Physician 2000;62:565-70 (Pubitemid 30643477)
68. Fraser JR, Kimpton WG, Pierscionek BK, et al. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Semin Arthritis Rheum 1993;22 Suppl. 1:9-17 (Pubitemid 23176279)
69. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanism on experimental joint pain in rats. Ann Rheum Dis 1993 Nov; 52(11):817-22 (Pubitemid 23328695)
70. Maneiro E, de Andres MC, Fernández-Sueiro JL, et al. The biologicalaction of hyaluronan on human osteoarthritic articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol 2004 May-Jun; 22(3):307-12 (Pubitemid 38585233)
71. Balazs EA. Hyaluronic acid and matrix implantation. Arlington (MA): Biotrix Inc., 1971
72. Balazs EA, Denlinger JL. Sodium hyaluronate acid and joint function. J Equine Vet Sci 1985;5:217-8
73. Weiss C, Balazs EA, St Onge R, et al. Clinical studies of the intra-articular injections of Healon (sodium hyaluronate) in the treatment of osteoarthritis of human knees. Semin Arthritis Rheum 1981;11:143-4 (Pubitemid 11009741)
74. Grogan KA, Chang TJ, Salk RS. Update on viscosupplementation in the treatment of osteoarthritis of the foot and ankle. Clin Podiatr Med Surg 2009 Apr; 26(2):199-204
75. Lee PB, Kim YC, Lim YJ, et al. Comparison between high and low molecular weight hyaluronates in knee osteoarthritis patients: open-label, randomized, multicentre clinical trial. J Int Med Res 2006 Jan-Feb; 34(1):77-87
76. Bongkotphet K, Tassanawipas W, Krittiyanunt S, et al. Comparative efficacy of low-and high-molecular weight intra-articular hyaluronic acids in patients with knee osteoarthritis. J Health Res 2009;23(2):87-92
77. Brzusek D, Petron D. Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 2008 Dec; 24(12):3307-22
78. Brander VA, Stadler TS. Functional improvement with hylan G-F 20 in patients with knee osteoarthritis. Phys Sportsmed 2009 Oct; 37(3):38-48
79. Conrozier T, Chevalier X. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis. Expert Opin Pharmacother 2008 Jul; 9(10):1797-804
80. Bannuru RR, Natov NS, Obadan IE, et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009 Dec. 15; 61(12):1704-11
81. Dagenais S. Intra-articular hyaluronic acid (viscosupplementation) for hip osteoarthritis. Issues Emerg Health Technol 2007 May; (98):1-4
82. Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006 Apr. 19; (2): CD005328
83. Nöth U, Steinert AF, Tuan RS. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 2008 Jul; 4(7):371-80 (Pubitemid 351974009)
84. Hepper CT, Halvorson JJ, Duncan ST, et al. The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies. J Am Acad Orthop Surg 2009 Oct; 17(10):638-46
85. Kruse DW. Intraarticular cortisone injection for osteoarthritis of the hip. Is it effective? Is it safe? Curr Rev Musculoskelet Med 2008 Dec; 1 (3-4): 227-33
86. Koyonos L, Yanke AB, McNickle AG, et al. A randomized, prospective, double-blind study to investigate the effectiveness of adding Depo Medrol to a local anesthetic injection in postmeniscectomy patients with osteoarthritis of the knee. Am J Sports Med 2009 Jun; 37(6):1077-82
87. Arden NK, Reading IC, Jordan KM, et al. A randomised controlled trial of tidal irrigation vs corticosteroid injection in knee osteoarthritis: the KIVIS Study. Osteoarthritis Cartilage 2008 Jun; 16(6):733-9
88. Ike RW. Tidal irrigation in septic arthritis of the knee: a potential alternative to surgical drainage. J Rheumatol 1993 Dec; 20(12):2104-11 (Pubitemid 24043136)
89. Fu P, Wu Y, Wu H, et al. Efficacy of intra-articular cocktail analgesic injection in total knee arthroplasty: a randomized controlled trial. Knee 2009 Aug; 16(4):280-4
90. Gazi MB, Sakata RK, Issy AM. Intra-articular morphine versus bupivacaine for knee motion among patients with osteoarthritis: randomized double-blind clinical trial. Sao Paulo Med J 2008 Nov; 126(6):309-13
91. Oztuna V, Eskandari M, Bugdayci R, et al. Intra-articular injection of tenoxicam in osteoarthritic knee joints with effusion. Orthopedics 2007 Dec; 30(12):1039-42 (Pubitemid 351184696)
92. Furuzawa-Carballeda J, Muñoz-Chablé OA, Mací asHernández SI, et al. Effect of polymerized-type I collagen in knee osteoarthritis: II. In vivo study. Eur J Clin Invest 2009 Jul; 39(7):598-606
93. Lazennec G, Jorgensen C. Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 2008 Jun; 26(6):1387-94
94. Chevalier X, Goupille P, Beaulieu AD, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009 Mar. 15; 61(3):344-52
95. Meijer H, Reinecke J, Tholen G, et al. The production of anti-inflammatory cytokines in whole blood by physicochemical induction. Inflamm Res 2003 Oct; 52(10):404-7 (Pubitemid 37260426)
96. Yang KG, Raijmakers NJ, van Arkel ER, et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage 2008 Apr; 16(4):498-505 (Pubitemid 351444567)
97. Fioravanti A, Fabbroni M, Cerase A, et al. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol Int 2009 Jun; 29(8):961-5
98. Boon AJ, Smith J, Dahm DL, et al. Efficacy of intraarticular botulinum toxin type A in painful knee osteoarthritis: a pilot study. PM R 2010 Apr; 2(4):268-76
99. Rossini M, Viapiana O, Ramonda R, et al. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology (Oxford) 2009 Jul; 48(7):773-8
100. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008 Feb; 16(2):137-62 (Pubitemid 351222155)
101. Zhang W, Robertson J, Jones AC, et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008 Dec; 67(12):1716-23
102. Needle pathology [Editorial]. C. M. A. Journal 1972;106:957
103. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2001;15:609-26 (Pubitemid 33026124)
104. Rozental TD, Sculco TP. Intra-articular corticosteroids: an updated overview. Am J Orthop 2000;29:18-23
105. Cole BJ, Schumacher HR. Injectable corticosteroids in modern practice. J Am Acad Orthop Surg 2005;13:37-46
106. Duclos M, Guinot M, Colsy M, et al. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc 2007;39(7):1036-43 (Pubitemid 47014130)
107. Sibbitt Jr WL, Peisajovich A, Michael AA, et al. Does sonographic needle guidance affect the clinical outcome of intraarticular injections? J Rheumatol 2009 Sep; 36(9):1892-902